Market Overview
According
to a new report by Market Research Future (MRFR), the global gallstone
market has been anticipated to expand at 7.9 % CAGR during the forecast period
(2017-2022) owing to the increase in gallbladder
diseases globally. Gallstones develop due to chemical
imbalance of bile inside the gallbladder. Stones generally formed as the
cholesterol level in bile increases and the cholesterol forms into stones. It has been predicted that in the UK, more than
one in every ten adults suffer from gallstones. Around 80 % of the people
suffering from gallstones don’t have pain as these are silent gallstones,
asserts American College of Gastroenterology.
Future Drivers and Restraints Impacting the Market
Major causes of gallstones
comprise blood sugar imbalance, estrogen dominance, food allergies and
sensitivities, chronic stress, low fiber
diet, low stomach acid production, obesity, rapid weight loss, low-fat diet, cholesterol-lowering
medications, and others. Moreover, the continuous
changing lifestyle coupled with unhealthy eating habits are also some of the
major factors propelling the market growth. With increasing demand for
treatment options, the gallstone market is likely to expand. Companies are
developing cost-effective products that
have minimum side effect. Several
companies are also adopting strategies for
acquisitions and launching new products to strive in the competitive market.
The competition amongst new market players is
also expected to upsurge the market growth.
Meanwhile, complications such as
infection, bleeding, bile leakage, bile duct injury,
deep vein thrombosis, post-cholecystectomy, and pain during the surgery
along with asymptomatic nature of
gallstones are predicted to slow down the
market growth over the assessment period.
No comments:
Post a Comment